Cortechs.ai key facts
- Developer of AI-powered imaging analysis software designed to optimise diagnostics for neurological and oncological conditions.
- Cortechs.ai’s last known valuation is $49.0M.
- It has raised $23.1M; the latest was Later Stage VC ($14.0M) in Nov 2024.
- Notable investors include National Institutes of Health, CONNECT(San Diego), Vitalis Ventures, Dragasac Limited, Genting — 11 tracked in total.
- Status: Privately Held (backing).
Who backs Cortechs.ai
11+Membership and data by Private Market View
- ·The complete investor list: 11 names
- ·Watch Cortechs.ai: the Monday email on marks, rounds and moves
Cortechs.ai funding rounds
No funding rounds for Cortechs.ai are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Cortechs.ai valuation
Cortechs.ai's last known valuation is $49 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Cortechs.ai investors
11 investors are on record for Cortechs.ai, including National Institutes of Health, CONNECT(San Diego), Vitalis Ventures and Dragasac Limited.
About Cortechs.ai
Developer of AI-powered imaging analysis software designed to optimise diagnostics for neurological and oncological conditions. The company's platform features pre- and post-operative 3D volume analysis of brain tumours, automated quantification of tracer activity, lesion segmentation and longitudinal tracking using multiple MRI modalities, and enhanced prostate MRI analysis, enabling medical institutions worldwide to access quantitative imaging insights that support clinical and research decision-making in brain and prostate health conditions.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 1996
- Employees
- 59
- Website
- cortechs.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Cortechs.ai’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.